Dipeptidyl peptidase-4/DPP-4 inhibitors and biguanide antidiabetic combinations are a form of hypoglycemic used to treat diabetes mellitus type 2. DPP-4 inhibitors block DPP-4, increasing incretin levels and inhibiting glucagon release. Biguanide antidiabetics improve the body's sensitivity to insulin and reduce the amount of sugar absorbed by the intestines. A commonly used dipeptidyl peptidase-4/DPP-4 inhibitors and biguanide antidiabetic combination is Janumet (sitagliptin, metformin, hydrochloride).
Drugs classified as Dipeptidyl Peptidase-4/DPP-4 Inhibitors and Biguanide Antidiabetic Combinations are frequently used to treat the following conditions:
Click on a drug below in order to find information and discounted prices at pharmacies near you.